Australia's most trusted
source of pharma news
Thursday, 25 April 2024
Posted 23 February 2022 PM
GSK has revealed that its consumer healthcare business will be called Haleon following its planned spin-off mid-2022, with Aussie staff set to move into brand new headquarters.
Anish Patel, ANZ General Manager designate of Haleon said, "the creation of Haleon is an exciting milestone as we move towards our future as a new, standalone consumer healthcare company".
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.